The 2022 Consensus Conference To Implement Optimal VTE Prophylaxis in Trauma will convene a multi-disciplinary group of stakeholders with wide ranging areas of expertise and focus in injury care and venous thromboembolism (VTE) in trauma. To be held May 4-5, 2022 in the offices of the American College of Surgeons in Chicago, the conference is presented by CNTR and co-led by VTE investigators Todd Costantini, MD, and Elliott Haut, MD, of UC San Diego and Johns Hopkins University, respectively.
The conference’s primary objectives are to promote research related to the perceived barriers to delivering timely pharmacologic VTE prophylaxis, support the development of education platforms and clinical care pathways to improve implementation of current guidelines, and develop research objectives for VTE prophylaxis in trauma.
“The group of leaders attending will not only discuss the latest in VTE prevention, but also develop the next generation of VTE research studies,” explained Dr. Costantini, MD. “Together, physicians, nurses, pharmacists and patient advocates will discuss the past, present, and future of VTE prophylaxis and treatments.”
Attendees will:
- Discuss guidelines for VTE prophylaxis in high-risk trauma patients that are accepted by trauma clinicians, surgical subspecialists, nurses, pharmacists, and patients that provide care to injured patients (and later help to disseminate these guidelines to respective specialty organizations)
- Address challenges to the dissemination and implementation of these guidelines across healthcare systems
- Define research priorities to measure short- and long-term outcomes for injured patients at risk for VTE, study the implementation of consensus guidelines, and investigate novel pharmacologic approaches to VTE prophylaxis
- Hear the voice of injured patients with VTE to promote patient-centered care research
Registration will open in January, 2022 for both in-person and virtual attendance.
Funding for this conference was made possible (in part) by 1R13HL 158206 from the National Heart, Lung and Blood Institute, awarded to CNTR. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.